Intensive Home-based Transcranial Direct Current Stimulation for Long COVID

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Hospital de Basurto
2 trials monitored
See all monitored trials
Anxiety
3,284 trials monitored
See 154 trials at risk
Depression
3,069 trials monitored
See 170 trials at risk
The goal of this clinical trial is to learn if home-based transcranial direct current stimulation (tDCS) works to treat fatigue and other symptoms in adults with Long COVID. It will also learn about the safety and home adherence of this intervention. The main questions it aims to answer are: Does active tDCS lower fatigue severity (FAS score) compared to sham treatment? What are the effects of the treatment sequence on cognition, pain, anxiety, depression, and quality of life? Researchers will compare a sequence of active tDCS followed by sham tDCS to a sequence of sham tDCS followed by active tDCS in a crossover design to see if the intervention works. Participants will: Receive a tapered schedule of home-based tDCS over 3 weeks per intervention period (totaling 42 sessions per intervention, separated by a 4-week washout period) Complete symptom evaluations and cognitive/clinical tests at baseline, after Phase 1, and after Phase 2 Log their daily sessions to track home adherence and report any potential side effects
Trial Details
NCT Number NCT07880171
Lead Sponsor Hospital de Basurto
Conditions
(from sponsor)		 Long COVID Fatigue, Brain Fog, Chronic Pain, Depression Anxiety Disorder
Related terms Chronic Pain, Fatigue, Mental Fatigue, Post-Acute COVID-19 Syndrome
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov